These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27736774)

  • 1. Enoyl-Acyl Carrier Protein Reductase I (FabI) Is Essential for the Intracellular Growth of Listeria monocytogenes.
    Yao J; Ericson ME; Frank MW; Rock CO
    Infect Immun; 2016 Dec; 84(12):3597-3607. PubMed ID: 27736774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).
    Yao J; Maxwell JB; Rock CO
    J Biol Chem; 2013 Dec; 288(51):36261-71. PubMed ID: 24189061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.
    Yao J; Abdelrahman YM; Robertson RM; Cox JV; Belland RJ; White SW; Rock CO
    J Biol Chem; 2014 Aug; 289(32):22365-76. PubMed ID: 24958721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria.
    Yao J; Bruhn DF; Frank MW; Lee RE; Rock CO
    J Biol Chem; 2016 Jan; 291(1):171-81. PubMed ID: 26567338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase.
    Dong H; Cronan JE
    Mol Microbiol; 2022 Nov; 118(5):541-551. PubMed ID: 36100979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically cryptic.
    Bi H; Zhu L; Wang H; Cronan JE
    J Bacteriol; 2014 Jan; 196(1):170-9. PubMed ID: 24163335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance.
    Zhu L; Bi H; Ma J; Hu Z; Zhang W; Cronan JE; Wang H
    mBio; 2013 Oct; 4(5):e00613-13. PubMed ID: 24085780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
    Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
    J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.
    Rao KN; Lakshminarasimhan A; Joseph S; Lekshmi SU; Lau MS; Takhi M; Sreenivas K; Nathan S; Yusof R; Abd Rahman N; Ramachandra M; Antony T; Subramanya H
    Protein Sci; 2015 May; 24(5):832-40. PubMed ID: 25644789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor.
    Kaplan N; Albert M; Awrey D; Bardouniotis E; Berman J; Clarke T; Dorsey M; Hafkin B; Ramnauth J; Romanov V; Schmid MB; Thalakada R; Yethon J; Pauls HW
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5865-74. PubMed ID: 22948878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
    Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
    Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunflower (Helianthus annuus) fatty acid synthase complex: enoyl-[acyl carrier protein]-reductase genes.
    González-Thuillier I; Venegas-Calerón M; Garcés R; von Wettstein-Knowles P; Martínez-Force E
    Planta; 2015 Jan; 241(1):43-56. PubMed ID: 25204631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.
    Zhu L; Lin J; Ma J; Cronan JE; Wang H
    Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kalimantacin/batumin biosynthesis operon encodes a self-resistance isoform of the FabI bacterial target.
    Mattheus W; Masschelein J; Gao LJ; Herdewijn P; Landuyt B; Volckaert G; Lavigne R
    Chem Biol; 2010 Oct; 17(10):1067-71. PubMed ID: 21035728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
    Zheng CJ; Sohn MJ; Chi SW; Kim WG
    J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.